Advertisement

International Ophthalmology

, Volume 33, Issue 2, pp 159–162 | Cite as

Peripapillary choroidal neovascularisation in the context of ocular syphilis is sensitive to combination antibiotic and corticosteroid treatment

  • Konstantinos BalaskasEmail author
  • Stephen Spencer
  • Yvonne D’Souza
Case Report

Abstract

Peripapillary choroidal neovascularisation (CNV) in the context of ocular syphilis is exceptional and little is known about its natural history and optimal therapeutic management. We report here a case of right eye peripapillary CNV with subretinal fluid encroaching on the fovea in a patient with mild bilateral ocular inflammation and cystoid macular oedema (CMO) in his contralateral eye. Extensive investigations revealed positive serology for active syphilitic infection. The patient received treatment with intravenous benzylpenicillin according to the algorithm for neurosyphilis complemented with oral corticosteroids as prophylaxis against Jarisch-Herxsheimer reaction for a period of 17 days. On the 15th day, receding of subretinal fluid in his right eye to a small pocket around the optic disc was identified as well as resolution of left eye CMO. We suggest that a course of antibiotic treatment for neurosyphilis with the addition of oral corticosteroids may be an effective therapeutic option for CNV in the context of ocular syphilis and thus more invasive treatment approaches are not warranted.

Keywords

Ocular syphilis Choroidal neovascularisation Treatment 

Notes

Conflict of interest

Y.D.S. has received travel grants from Novartis and Allergan and been on the advisory board. No financial or proprietary interests exist for any author. The authors report no conflicts of interest.

References

  1. 1.
    Gaudio PA (2006) Update on ocular syphilis. Curr Opin Ophthalmol 17(6):562–566PubMedCrossRefGoogle Scholar
  2. 2.
    Halperin LS, Lewis H, Blumenkranz MS, Gass JD et al (1989) Choroidal neovascular membrane and other chorioretinal complications of acquired syphilis. Am J Ophthalmol 108(5):554–562PubMedGoogle Scholar
  3. 3.
    Dhingra N, Kelly S, Majid MA, Bailey CB, Dick AD (2010) Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment. Indian J Ophthalmol 58(1):3–10PubMedCrossRefGoogle Scholar
  4. 4.
    Browning DJ, Fraser CM (2005) Ocular conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes. Ophthalmology 112(6):1054–1061PubMedCrossRefGoogle Scholar
  5. 5.
    The Macular Photocoagulation Study Group (1995) Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Arch Ophthalmol 113(1):56–61CrossRefGoogle Scholar
  6. 6.
    Hoeh AE, Schaal KB, Ach T, Dithmar S (2009) Treatment of peripapillary choroidal neovascularization with intravitreal bevacizumab. Eur J Ophthalmol 19(1):163–165PubMedGoogle Scholar
  7. 7.
    Figueroa MS, Noval S, Contreras I (2008) Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab. Br J Ophthalmol 92(9):1244–1247PubMedCrossRefGoogle Scholar
  8. 8.
    Doris JP, Saha K, Jones NP, Sukthankar A (2006) Ocular syphilis: the new epidemic. Eye (Lond) 20(6):703–705CrossRefGoogle Scholar
  9. 9.
    Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ (1998) The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond) 12(Pt 2):266–272CrossRefGoogle Scholar
  10. 10.
    Brown J Jr, Folk JC, Reddy CV, Kimura AE (1996) Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 103(7):1100–1105PubMedGoogle Scholar
  11. 11.
    Olk RJ, Burgess DB, McCormick PA (1984) Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology 91(12):1592–1602PubMedGoogle Scholar
  12. 12.
    Schlaegel TF Jr (1983) Corticosteroids in the treatment of ocular histoplasmosis. Int Ophthalmol Clin 23(2):111–123PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Konstantinos Balaskas
    • 1
    • 3
    Email author
  • Stephen Spencer
    • 2
  • Yvonne D’Souza
    • 1
  1. 1.Manchester Royal Eye Hospital, Central Manchester Healthcare Foundation TrustManchesterUK
  2. 2.Calderdale and Huddersfield NHS TrustHalifaxUK
  3. 3.Moorfields Eye HospitalLondonUK

Personalised recommendations